With exquisitely bad timing, the National Institutes of Heath (NIH) floated a new policy governing licensing inventions made by its scientists subtitled “Promoting Equity in Access Planning.”. With stakeholders still stunned by the Administration’s attempt to misuse the Bayh-Dole Act to impose Washington price controls on products based on federally funded inventions, the new plan could hardly have been floated at a worse time. The document asks for public comments by July 22, 2024.
Recent Posts
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges
- The USPTO Should Reintroduce the AFCP Program—Now
- What Fintiv v. PayPal Means for Software and AI Patent Practice
- Despite Tweaks, PREVAIL 2025 Would Still Transform the PTAB